These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34223879)

  • 41. Intramuscular injection of botulinum toxin as an adjunct to arthrocentesis of the temporomandibular joint: preliminary observations.
    Freund BJ; Schwartz M
    Br J Oral Maxillofac Surg; 2003 Oct; 41(5):351-2. PubMed ID: 14581034
    [No Abstract]   [Full Text] [Related]  

  • 42. Exploring botulinum toxin's impact on masseter hypertrophy: a randomized, triple-blinded clinical trial.
    de Souza Nobre BB; Rezende L; Barbosa Câmara-Souza M; Sanchez-Ayala A; Blass R; Carbone AC; Manso AC; Ernberg M; Christidis N; De la Torre Canales G
    Sci Rep; 2024 Jun; 14(1):14522. PubMed ID: 38914688
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The treatment of masseter hypertrophy with botulinum toxin type A.
    Al-Ahmad HT; Al-Qudah MA
    Saudi Med J; 2006 Mar; 27(3):397-400. PubMed ID: 16532107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy.
    Ahn KY; Kim ST
    Plast Reconstr Surg; 2007 Nov; 120(6):1662-1666. PubMed ID: 18040203
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Botulinum toxin type A treatment for contouring of the lower face.
    Park MY; Ahn KY; Jung DS
    Dermatol Surg; 2003 May; 29(5):477-83; discussion 483. PubMed ID: 12752514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botulinum Toxin Injection Technique for Reducing the Masseter Size and Enhancing the Jawline.
    Zhuang J; Jiang L; Zhou Y; Wang C; Chen Y; Su X; Wei Q; Zhang Z; Hu J
    Aesthet Surg J; 2024 Jul; 44(8):NP567-NP573. PubMed ID: 38494986
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of botulinum toxin in masseter muscle hypertrophy for lower face contouring.
    Kundu N; Kothari R; Shah N; Sandhu S; Tripathy DM; Galadari H; Gold MH; Goldman MP; Kassir M; Schepler H; Grabbe S; Goldust M
    J Cosmet Dermatol; 2022 May; 21(5):1849-1856. PubMed ID: 35176198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Comprehensive Ultrasound Evaluation Approach of Lower Facial Structure Before Masseter Muscle Botulinum Toxin Injection.
    Li Z; Chi Y; Chen C; Jin L; Huang J; Long X; Yu N
    Aesthet Surg J; 2023 Mar; 43(4):NP283-NP292. PubMed ID: 36527687
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Botulinum Toxin Injections for Masseter Reduction in East Asians.
    Cheng J; Hsu SH; McGee JS
    Dermatol Surg; 2019 Apr; 45(4):566-572. PubMed ID: 30883483
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
    Baş B; Ozan B; Muğlali M; Celebi N
    Med Oral Patol Oral Cir Bucal; 2010 Jul; 15(4):e649-52. PubMed ID: 20173718
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Autogenous Fat Transplantation and Botulinum Toxin Injection Into the Masseter Muscle to Create an Ideal Oval Face.
    Zheng Z; Hao Y; Yin J; Lei X; Cheng B; Huang W
    Aesthet Surg J; 2021 May; 41(6):NP579-NP588. PubMed ID: 33861312
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A pilot study comparing the efficacy of two formulations of botulinum toxin type A for muscular calves contouring.
    Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Sathaworawong A; Vanadurongwan B; Lektrakul N
    J Cosmet Dermatol; 2018 Dec; 17(6):984-990. PubMed ID: 30203534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement.
    To EW; Ahuja AT; Ho WS; King WW; Wong WK; Pang PC; Hui AC
    Br J Plast Surg; 2001 Apr; 54(3):197-200. PubMed ID: 11254408
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of botulinum toxin in pediatric spasticity (cerebral palsy).
    Berweck S; Heinen F
    Mov Disord; 2004 Mar; 19 Suppl 8():S162-7. PubMed ID: 15027070
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A Pilot Study on the Treatment of Posterior Cheek Enlargement in HIV+ Patients With Botulinum Toxin A.
    Scali C; Carruthers A; Malpas D; Humphrey S
    Dermatol Surg; 2015 Nov; 41(11):1300-8. PubMed ID: 26469200
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of Two Botulinum Toxin Type a Evaluated by Shear Wave Elastography and Electromyographic Measurements of Masseter Reduction.
    Guo Y; Diao X; Dong D; Xia W; Liu T; Zhou Y; Zhu J; Chen L; Chen Y
    J Craniofac Surg; 2022 Jul-Aug 01; 33(5):1450-1453. PubMed ID: 35758504
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of clinical marking and ultrasound-guided injection of Botulinum type A toxin into the masseter muscles for treating bruxism and its cosmetic effects.
    Quezada-Gaon N; Wortsman X; Peñaloza O; Carrasco JE
    J Cosmet Dermatol; 2016 Sep; 15(3):238-44. PubMed ID: 26799545
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Unilateral masseter muscle hypertrophy: morphofunctional analysis of the relapse after treatment with botulinum toxin.
    Peretta R; Melison M; Meneghello R; Comelli D; Guarda L; Galzignato PF; Concheri G; Ferronato G
    Cranio; 2009 Jul; 27(3):200-10. PubMed ID: 19697649
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discussion on The risorius muscle: anatomic considerations with reference to botulinum neurotoxin injection for masseteric hypertrophy.
    Hwang K
    Dermatol Surg; 2014 Dec; 40(12):1340-1. PubMed ID: 25380090
    [No Abstract]   [Full Text] [Related]  

  • 60. Change of distribution and timing of bite force after botulinum toxin type A injection evaluated by a computerized occlusion analysis system.
    Song JH; Cho ES; Kim ST; Ahn HJ
    Yonsei Med J; 2014 Jul; 55(4):1123-9. PubMed ID: 24954346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.